Ependymomas factors in clinical and diagnostic staging
- 1 October 1985
- Vol. 56 (S7) , 1812-1816
- https://doi.org/10.1002/1097-0142(19851001)56:7+<1812::aid-cncr2820561319>3.0.co;2-1
Abstract
In ependymoma, there is evidence that indicates that age, sex, histologic patterns, functional status, location, duration of symptoms, size, and accessibility to surgical removal influence survival. The role of neuron-specific enolase and other biologic markers must await the accumulation of further information. Further advances in diagnostic imaging, immunodiagnostics, and intraoperative staging should lead to a better understanding of the disease and pinpoint prognostic factors more precisely. A profile that contains important information is suggested; this should eventually lead to the development of a staging system.Keywords
This publication has 11 references indexed in Scilit:
- A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomasInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Ependymomas: Results of radiation treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980International Journal of Radiation Oncology*Biology*Physics, 1982
- Intracranial Secondary Carcinomas and Disseminating Gliomas: Treatment and PrognosisPublished by Springer Nature ,1979
- Intracranial EpendymomasRadiology, 1977
- Ependymomas and ependymoblastomas in childrenJournal of Neurosurgery, 1976
- EpendymomasJournal of Neurosurgery, 1970
- Ependymomas: Clinical and Pathological AspectsJournal of Neurosurgery, 1969
- Considerations in the Treatment of EpendymomaRadiology, 1965
- Therapeutic Considerations in Tumors Affecting The Central Nervous System: EpendymomasRadiology, 1964